Clinical Trial Update: Intravenous Microdose Pharmacokinetic (PK) Study With [14C]-GSK2239633 [Phase 1]

View source ↗

Summary

A Phase 1 intravenous microdose pharmacokinetic study of [14C]-GSK2239633 for asthma sponsored by GlaxoSmithKline has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GSK2239633

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED